Business
Withdrawal of AGM Resolutions 9 and 10
Withdrawal of AGM Resolutions 9 and 10.
About this update from Surgical Innovations Group Plc
[{"type":"text","content":"\n\nSurgical Innovations Group plc\n(\"Surgical Innovations\", the \"Company\", or the \"Group\")\n \nWithdrawal of AGM Resolutions 9 and 10\n \nSurgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery (\"MIS\"), advises that the Board has withdrawn Resolutions 9 and 10 from the agenda of the Annual General Meeting (\"AGM\") of the Company's shareholders scheduled to be held at 11:00 a.m. tomorrow, 27 June 2025, at the offices of Singer Capital Markets at 1 Bartholomew Lane, London, EC2N 2AX.\n \nResolutions 9 and 10 were special resolutions relating to the disapplication of pre-emption rights in respect of the allotment of equity securities for cash with limits in line with the Pre-Emption Group's 2022 Statement of Principles. Whilst the Board considers the flexibility afforded by these authorities to be in the best interests of the Company, it has taken the decision to withdraw Resolutions 9 and 10 from the agenda of the AGM following feedback received from a small number of significant shareholders in the Company since the publication of the notice of the AGM.\n \nThe withdrawal of Resolutions 9 and 10 does not affect the validity of the notice of the AGM, the proxy form or any votes submitted in respect of the remaining resolutions to be proposed at the AGM. Arrangements for the AGM are unchanged from those previously notified as is the numbering of all other proposed resolutions at the AGM.\n \nThe withdrawal of Resolutions 9 and 10 does not affect the strategy or the day-to-day running of the business and the Directors do not currently envisage that the business would need to raise new funds through the issue of new shares on a non pre-emptive basis before the 2026 AGM. Should such need arise, a separate General Meeting would be convened to seek shareholder approval at the relevant time.\n \n \n \nFor further information please contact:\n \n\n\n\n\nSurgical Innovations Group plc\n\n\nwww sigroupplc com\n\n\n\n\nDavid Marsh, CEO\n\n\nTel: 0113 230 7597\n\n\n\n\nBrent Greetham, CFO\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Broker)\n\n\nTel: 020 7496 3000\n\n\n\n\nAlex Bond / Oliver Platts\n\n\n \n\n\n\n\n\n\n\n&nb...